These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
305 related articles for article (PubMed ID: 32990680)
1. PDX-derived organoids model in vivo drug response and secrete biomarkers. Huang L; Bockorny B; Paul I; Akshinthala D; Frappart PO; Gandarilla O; Bose A; Sanchez-Gonzalez V; Rouse EE; Lehoux SD; Pandell N; Lim CM; Clohessy JG; Grossman J; Gonzalez R; Del Pino SP; Daaboul G; Sawhney MS; Freedman SD; Kleger A; Cummings RD; Emili A; Muthuswamy LB; Hidalgo M; Muthuswamy SK JCI Insight; 2020 Nov; 5(21):. PubMed ID: 32990680 [TBL] [Abstract][Full Text] [Related]
2. Pancreatic cancer-derived organoids - a disease modeling tool to predict drug response. Frappart PO; Walter K; Gout J; Beutel AK; Morawe M; Arnold F; Breunig M; Barth TF; Marienfeld R; Schulte L; Ettrich T; Hackert T; Svinarenko M; Rösler R; Wiese S; Wiese H; Perkhofer L; Müller M; Lechel A; Sainz B; Hermann PC; Seufferlein T; Kleger A United European Gastroenterol J; 2020 Jun; 8(5):594-606. PubMed ID: 32213029 [TBL] [Abstract][Full Text] [Related]
3. Shared extracellular vesicle miRNA profiles of matched ductal pancreatic adenocarcinoma organoids and blood plasma samples show the power of organoid technology. Zeöld A; Sándor GO; Kiss A; Soós AÁ; Tölgyes T; Bursics A; Szűcs Á; Harsányi L; Kittel Á; Gézsi A; Buzás EI; Wiener Z Cell Mol Life Sci; 2021 Mar; 78(6):3005-3020. PubMed ID: 33237353 [TBL] [Abstract][Full Text] [Related]
4. Quantification of fluorophore distribution and therapeutic response in matched in vivo and ex vivo pancreatic cancer model systems. Solanki A; King D; Thibault G; Wang L; Gibbs SL PLoS One; 2020; 15(2):e0229407. PubMed ID: 32097436 [TBL] [Abstract][Full Text] [Related]
5. Patient-derived tumor xenograft and organoid models established from resected pancreatic, duodenal and biliary cancers. Pham NA; Radulovich N; Ibrahimov E; Martins-Filho SN; Li Q; Pintilie M; Weiss J; Raghavan V; Cabanero M; Denroche RE; Wilson JM; Metran-Nascente C; Borgida A; Hutchinson S; Dodd A; Begora M; Chadwick D; Serra S; Knox JJ; Gallinger S; Hedley DW; Muthuswamy L; Tsao MS Sci Rep; 2021 May; 11(1):10619. PubMed ID: 34011980 [TBL] [Abstract][Full Text] [Related]
6. Discovery of New Targets to Control Metastasis in Pancreatic Cancer by Single-cell Transcriptomics Analysis of Circulating Tumor Cells. Dimitrov-Markov S; Perales-Patón J; Bockorny B; Dopazo A; Muñoz M; Baños N; Bonilla V; Menendez C; Duran Y; Huang L; Perea S; Muthuswamy SK; Al-Shahrour F; Lopez-Casas PP; Hidalgo M Mol Cancer Ther; 2020 Aug; 19(8):1751-1760. PubMed ID: 32499301 [TBL] [Abstract][Full Text] [Related]
7. Circulating extracellular vesicle-encapsulated HULC is a potential biomarker for human pancreatic cancer. Takahashi K; Ota Y; Kogure T; Suzuki Y; Iwamoto H; Yamakita K; Kitano Y; Fujii S; Haneda M; Patel T; Ota T Cancer Sci; 2020 Jan; 111(1):98-111. PubMed ID: 31715081 [TBL] [Abstract][Full Text] [Related]
8. Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis. Matsuura T; Maru Y; Izumiya M; Hoshi D; Kato S; Ochiai M; Hori M; Yamamoto S; Tatsuno K; Imai T; Aburatani H; Nakajima A; Hippo Y Carcinogenesis; 2020 Jun; 41(4):490-501. PubMed ID: 31233118 [TBL] [Abstract][Full Text] [Related]
9. Aspartate β-hydroxylase promotes pancreatic ductal adenocarcinoma metastasis through activation of SRC signaling pathway. Ogawa K; Lin Q; Li L; Bai X; Chen X; Chen H; Kong R; Wang Y; Zhu H; He F; Xu Q; Liu L; Li M; Zhang S; Nagaoka K; Carlson R; Safran H; Charpentier K; Sun B; Wands J; Dong X J Hematol Oncol; 2019 Dec; 12(1):144. PubMed ID: 31888763 [TBL] [Abstract][Full Text] [Related]
10. miR-365 secreted from M2 Macrophage-derived extracellular vesicles promotes pancreatic ductal adenocarcinoma progression through the BTG2/FAK/AKT axis. Li X; Xu H; Yi J; Dong C; Zhang H; Wang Z; Miao L; Zhou W J Cell Mol Med; 2021 May; 25(10):4671-4683. PubMed ID: 33811437 [TBL] [Abstract][Full Text] [Related]
11. Pattern of Invasion in Human Pancreatic Cancer Organoids Is Associated with Loss of SMAD4 and Clinical Outcome. Huang W; Navarro-Serer B; Jeong YJ; Chianchiano P; Xia L; Luchini C; Veronese N; Dowiak C; Ng T; Trujillo MA; Huang B; Pflüger MJ; Macgregor-Das AM; Lionheart G; Jones D; Fujikura K; Nguyen-Ngoc KV; Neumann NM; Groot VP; Hasanain A; van Oosten AF; Fischer SE; Gallinger S; Singhi AD; Zureikat AH; Brand RE; Gaida MM; Heinrich S; Burkhart RA; He J; Wolfgang CL; Goggins MG; Thompson ED; Roberts NJ; Ewald AJ; Wood LD Cancer Res; 2020 Jul; 80(13):2804-2817. PubMed ID: 32376602 [TBL] [Abstract][Full Text] [Related]
12. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Xie Y; Zhu S; Zhong M; Yang M; Sun X; Liu J; Kroemer G; Lotze M; Zeh HJ; Kang R; Tang D Gastroenterology; 2017 Nov; 153(5):1429-1443.e5. PubMed ID: 28764929 [TBL] [Abstract][Full Text] [Related]
13. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer. Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835 [TBL] [Abstract][Full Text] [Related]
14. Patient-derived pancreatic tumour organoids identify therapeutic responses to oncolytic adenoviruses. Raimondi G; Mato-Berciano A; Pascual-Sabater S; Rovira-Rigau M; Cuatrecasas M; Fondevila C; Sánchez-Cabús S; Begthel H; Boj SF; Clevers H; Fillat C EBioMedicine; 2020 Jun; 56():102786. PubMed ID: 32460166 [TBL] [Abstract][Full Text] [Related]
15. Cancer-initiating cells in human pancreatic cancer organoids are maintained by interactions with endothelial cells. Choi JI; Jang SI; Hong J; Kim CH; Kwon SS; Park JS; Lim JB Cancer Lett; 2021 Feb; 498():42-53. PubMed ID: 33188841 [TBL] [Abstract][Full Text] [Related]
16. Modelling of pancreatic cancer biology: transcriptomic signature for 3D PDX-derived organoids and primary cell line organoid development. Nelson SR; Zhang C; Roche S; O'Neill F; Swan N; Luo Y; Larkin A; Crown J; Walsh N Sci Rep; 2020 Feb; 10(1):2778. PubMed ID: 32066753 [TBL] [Abstract][Full Text] [Related]
17. Correlation between drug sensitivity profiles of circulating tumour cell-derived organoids and clinical treatment response in patients with pancreatic ductal adenocarcinoma. Wu YH; Hung YP; Chiu NC; Lee RC; Li CP; Chao Y; Shyr YM; Wang SE; Chen SC; Lin SH; Chen YH; Kang YM; Hsu SM; Yen SH; Wu JY; Lee KD; Tseng HE; Tsai JR; Tang JH; Chiou JF; Burnouf T; Chen YJ; Wang PY; Lu LS Eur J Cancer; 2022 May; 166():208-218. PubMed ID: 35306319 [TBL] [Abstract][Full Text] [Related]
18. Generation and application of patient-derived xenograft models in pancreatic cancer research. Wang CF; Shi XJ Chin Med J (Engl); 2019 Nov; 132(22):2729-2736. PubMed ID: 31725451 [TBL] [Abstract][Full Text] [Related]
19. Tumor-Specific Delivery of 5-Fluorouracil-Incorporated Epidermal Growth Factor Receptor-Targeted Aptamers as an Efficient Treatment in Pancreatic Ductal Adenocarcinoma Models. Mahajan UM; Li Q; Alnatsha A; Maas J; Orth M; Maier SH; Peterhansl J; Regel I; Sendler M; Wagh PR; Mishra N; Xue Y; Allawadhi P; Beyer G; Kühn JP; Marshall T; Appel B; Lämmerhirt F; Belka C; Müller S; Weiss FU; Lauber K; Lerch MM; Mayerle J Gastroenterology; 2021 Sep; 161(3):996-1010.e1. PubMed ID: 34097885 [TBL] [Abstract][Full Text] [Related]
20. Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN. Yang KS; Ciprani D; O'Shea A; Liss AS; Yang R; Fletcher-Mercaldo S; Mino-Kenudson M; Fernández-Del Castillo C; Weissleder R Gastroenterology; 2021 Mar; 160(4):1345-1358.e11. PubMed ID: 33301777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]